Parametrica Management’s Altimmune ALT Stock Holding History

Parametrica Management’s Portfolio ALT Stock Details ALT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-43,651	Closed	-$591K	–	101
2021 Q1	$591K	Buy	43,651 +22,773	+109%	+$368K	0.28%	70
2020 Q4	$236K	Buy	+20,878	New	+$246K	0.15%	136

Other funds holding ALT

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VR Adviser New York $2.68B AUM 422.73% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Parametrica Management's ALT Position: Q2 2021 in Review

Parametrica Management sold out of Altimmune (ALT) in Q2 2021, closing a stake of 43,651 shares — an estimated $591K sold.

Parametrica Management first reported a position in ALT in Q4 2020 and held it in 2 quarters. The position peaked at $591K in Q1 2021. 109 funds tracked by Wall St. Rank hold ALT as of Q2 2021.

Parametrica Management reported no remaining Altimmune position as of Q2 2021 after selling out during the quarter.
Parametrica Management sold 43,651 Altimmune shares in Q2 2021, an estimated $591K.
Parametrica Management first reported a position in Altimmune in Q4 2020 and held it in 2 quarters.
Parametrica Management's Altimmune position peaked at $591K in Q1 2021.
109 funds tracked by Wall St. Rank held Altimmune as of Q2 2021.

Based on Parametrica Management's 13F filing for Q2 2021, filed 13 Aug 2021.